Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorBicetre Hospital

About this trial

Fluid responsiveness is a critical determinant guiding fluid therapy in critically ill patients. However, excessive fluid administration can result in fluid overload, leading to venous congestion and worse clinical outcomes. Venous congestion, a marker of impaired fluid clearance, is increasingly recognized as a significant contributor to poor prognosis. Previous studies have demonstrated the coexistence of fluid responsiveness and venous congestion in critically ill patients. Notably, these studies were limited by the absence of fluid challenge-the gold standard for assessing fluid responsiveness-leaving the dynamic relationship between fluid responsiveness and venous congestion incompletely understood. This study aims to investigate the interplay and temporal evolution of fluid responsiveness and venous congestion following a standardized fluid challenge in critically ill patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years

Hospitalized in the intensive care unit (ICU)

Hemodynamic monitoring in place, with a pulse wave contour analysis- derived estimation of cardiac output (either calibrated or uncalibrated)

Decision made by clinicians to perform volume expansion through intravenous infusion of crystalloid fluid

Disqualifiers

Pregnancy

Refusal to participate by relatives of the patient or the patient himself

Trial population

Critically ill patients with evidence of inadequate tissue perfusion, who are already monitored using a pulse wave contour analysis-derived estimation of cardiac output (either calibrated or uncalibrated),and for whom clinicians have decided to administer volume expansion through intravenous crystalloid infusion.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

64 Participants
are grouped into 2 trial groups
Group A: Fluid Responder
Group B: Fluid Non-responder

Trial outcomes

Primary outcomes

1

The difference in venous congestion (VExUS) changes between fluid responders and non-responders following a fluid challenge.

Time frame
before and after 15-minute fluid challenge.

Secondary outcomes

1

The differential evolution of venous congestion (VExUS) changes between fluid responders and non-responders 1 hour after a fluid challenge.

Time frame
1 hour after fluid challenge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bicetre Hospital

Lead sponsor

First Affiliated Hospital, Sun Yat-Sen University

Collaborator

Longgang District People's Hospital of Shenzhen

Collaborator